Search
-
Ipsos Healthcare Launches ‘NASH’ Therapy Monitor
Ipsos Healthcare has launched its Nonalcoholic Steatohepatitis (NASH) Therapy Monitor in the US and EU5 initially – France, Germany, Italy, Spain, and UK – with other markets available on demand.
-
2016 US Elections - Clinton Leads by 9 Points to Trump’s (June 16)
Barack Obama’s approval rating is at 48% this week. This is the fourth week in a row where the President’s approval rating has (narrowly) exceeded his disapproval rating on the last Ipsos/Reuters Poll.
-
International Survey on Connected Health: Coming Ready or Not!
Connected Health – sometimes referred to as Digital Health – is a potential game-changer for global healthcare.
-
2016 US Elections - The Race Between Clinton and Trump is Essentially Unchanged (June 9)
Barack Obama’s approval rating slides to 49% this week. But, this is the third week in a row where the President’s approval rating has (narrowly) exceeded his disapproval rating on the last Ipsos/Reuters Poll.
-
2016 US Elections - Clinton Now Up 9% Points to Trump’s (June 2)
Barack Obama’s approval rating is up to 52% this week. This is the highest approval rating the Reuters/Ipsos poll has shown since 2012.
-
Brexit and the UK Pharma Industry
The ‘In’ and ‘Out’ campaigns are now intensifying, but ‘Brexit’ has been a constant topic of conversation since the referendum date was announced 3 months ago. A British exit could have widespread repercussions for many sectors within the UK economy, especially in highly regulated and controlled industries such as pharmaceuticals.
-
Ipsos Healthcare Launches SyndicatedPD-L1Testing Monitor in Oncology
Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.
-
2016 US Elections - Clinton Continues to Lead Trump (May 26)
Barack Obama’s approval rating is at 47% this week on the alst Ipsos/Reuters Poll: Core Political Approval
-
2016 US Elections - Clinton Continues to Lead Trump (May 20)
Barack Obama’s approval rating is at 48% this week on the last Ipsos/Reuters Poll : Core Political Approval
-
Who Will Win the Race to Treat NASH?
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.